Skip to main content
Log in

Chimerism does not predict for outcome after alemtuzumab based conditioning

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Artz A, Pollyea D, Kocherginsky M, Stock W, Rich E, Odenike O et al. Performance status and comorbidity predict transplant related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006; 12: 954–964.

    Article  Google Scholar 

  2. van Besien K, Artz A, Smith S, Cao D, Rich S, Godley L et al. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005; 23: 5728–5738.

    Article  CAS  Google Scholar 

  3. Michaelis L, Sher D, Myers M, Siddiqui M, Collins-Jones D, Ulaszek J et al. Prognostic significance of WT-1 levels in patients with myelodysplastic syndrome and leukemia after reduced-intensity allogeneic transplantation [abstract]. Proc Am Soc Clin Oncol 2006; 24: 6524a.

    Google Scholar 

  4. Girgis M, Hallemeier C, Blum W, Brown R, Lin HS, Khoury H et al. Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide. Blood 2005; 105: 3035–3041.

    Article  CAS  Google Scholar 

  5. Huisman C, De Weger RA, Devries L, Tilanus MLJ, Verdonck LF . Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia. Bone Marrow Transplant 2007; 39: 285–291.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K van Besien.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michaelis, L., Lin, S., Joseph, L. et al. Chimerism does not predict for outcome after alemtuzumab based conditioning. Bone Marrow Transplant 40, 181 (2007). https://doi.org/10.1038/sj.bmt.1705707

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705707

  • Springer Nature Limited

This article is cited by

Navigation